IP Library Granted Patent US 7,947,513
Granted Patent B2
US 7,947,513 · App. 11/673,809 · Granted May 24, 2011

Sets and compositions pertaining to analyte determination

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,947,513
App. No.
11/673,809
Granted
May 24, 2011
Kind
B2
Abstract

This invention pertains to methods, kits and/or compositions for the determination of analytes by mass analysis using unique labeling reagents or sets of unique labeling reagents. The labeling reagents can be isomeric or isobaric and can be used to produce mixtures suitable for multiplex analysis of the labeled analytes.

Claims (34)

1. A set of two or more reagent compounds, or a salt thereof, each of the formula RP-X-LK-Y-RG, wherein:

i) RG is a reactive group that is a nucleophile or an electrophile and that is capable of reacting with a functional group of one or more reactive analytes of a sample;

ii) RP is a reporter moiety that comprises a fixed charge or that is ionizable, wherein the gross mass of each reporter moiety is different for each reagent compound of the set;

iii) LK is a linker moiety that links the reactive group to the reporter moiety, wherein the mass of the linker compensates for the difference in gross mass between the reporter moieties for the different reagent compounds of the set such that the aggregate gross mass of the reporter and linker combination is the same for each reagent compound of the set;

iv) X is a bond between an atom of the reporter moiety and an atom of the linker moiety;

v) Y is a bond between an atom of the linker moiety and an atom of the reactive group, wherein, once the reagent compound is reacted with the reactive analyte, bond Y links the linker to the analyte; and

vi) bonds X and Y are configured to fragment to form a labeled analyte when subjected to dissociative energy levels;

wherein the reporter moiety, RP, of each of the reagent compounds is independently a substituted or unsubstituted morpholine, or a substituted or unsubstituted piperazine, the nitrogen atom of the morpholine or a nitrogen atom of the piperazine is N-alkylated with a substituted or unsubstituted acetic acid moiety, the acetic acid moiety represents X-LK-Y, and the carbonyl group of the acetic acid moiety is linked to the reactive group, RG, to which the analyte can be linked, by reaction of the reactive group, RG, with the functional group of the analyte, and each of the two or more reagent compounds independently comprises one or more heavy atom isotopes.

2. The compound set of claim 1 , wherein the reporter moiety, RP:

i) has a gross mass of less than 250 daltons; and/or

ii) does not substantially sub-fragment under conditions of dissociative energy applied to cause fragmentation of at least a portion of both bonds X and Y of a labeled analyte in a mass spectrometer; and/or

iii) is not a polymer or is not a biological polymer.

3. The compound set of claim 1 , wherein the linker moiety, LK, undergoes neutral loss under conditions of applied dissociative energy.

4. The compound set of claim 1 , wherein under conditions of dissociative energy applied in a mass spectrometer, the fragmentation of one of bonds X or Y of the reagent compounds results in the fragmentation of the other of bonds X or Y.

5. The compound set of claim 1 , wherein:

i) under conditions of dissociative energy applied in a mass spectrometer, bond X of the reagent compounds is less prone to fragmentation as compared with bond Y; and/or

ii) under conditions of dissociative energy applied in a mass spectrometer, bond X of the reagents is less prone to fragmentation as compared with the peptide bond of a Z″-pro amino acid dimer or Z″-asp amino acid dimer, wherein Z″ is any natural amino acid, pro is proline and asp is aspartic acid.

6. The compound set of claim 1 , wherein compounds of the set are isotopically enriched with two or more heavy atom isotopes.

7. The compound set of claim 1 , wherein compounds of the set are isotopically enriched with three or more heavy atom isotopes.

8. The compound set of claim 1 , wherein the reactive group is an active ester.

9. The compound set of claim 1 , wherein the reactive group is a mixed anhydride.

10. The compound set of claim 1 , wherein each reagent compound is in its salt form as a mono-TFA salt, a mono-HCl salt, a bis-TFA salt or a bis-HCl salt.

11. The compound set of claim 1 , wherein each incorporated heavy atom isotope of each reagent compound is present in at least 80 percent isotopic purity.

12. The compound set of claim 1 , wherein each incorporated heavy atom isotope of each reagent compound is present in at least 93 percent isotopic purity.

13. The compound set of claim 1 , wherein each incorporated heavy atom isotope of each reagent compound is present in at least 96 percent isotopic purity.

14. A reagent compound of formula RP-X-LK-Y-RG, or a salt thereof, wherein:

i) RG is a reactive group that is a nucleophile or an electrophile and that is capable of reacting with a functional group of one or more reactive analytes of a sample;

ii) RP is a reporter moiety that comprises a fixed charge or that is ionizable;

iii) LK is a linker moiety that links the reactive group to the reporter moiety;

iv) X is a bond between an atom of the reporter moiety and an atom of the linker moiety;

v) Y is a bond between an atom of the linker moiety and an atom of the reactive group, wherein, once the reagent compound is reacted with the reactive analyte, bond Y links the linker to the analyte; and

vi) bonds X and Y are configured to fragment to form a labeled analyte upon reacting the compound of formula RP-X-LK-Y-RG with a sample comprising one or more reactive analytes to form a product and subjecting the product to dissociative energy levels; wherein, the linker moiety of the compound is isotopically enriched with at least one heavy atom isotope and the reporter moiety of the compound is isotopically enriched with at least one heavy atom isotope;

wherein the reporter moiety, RP, is a substituted or unsubstituted morpholine, or substituted or unsubstituted piperazine, the nitrogen atom of the morpholine or a nitrogen atom of the piperazine is N-alkylated with a substituted or unsubstituted acetic acid moiety, the acetic acid moiety represents X-LK-Y, and the carbonyl group of the acetic acid moiety is linked to the reactive group, RG, to which the analyte can be linked, by reaction of the reactive group, RG, with the functional group of the analyte.

15. The reagent compound of claim 14 , wherein the linker moiety is capable of undergoing neutral loss when the reagent compound is subjected to dissociative energy.

Assignments (8)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038007/0115 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
RELEASE OF SECURITY INTEREST Recorded Mar 31, 2010
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 024160/0955 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2010
From: APPLIED BIOSYSTEMS, LLC
To: DH TECHNOLOGIES PTE. LTD.
Reel/Frame 023937/0854 →
MERGER Recorded Aug 26, 2009
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023146/0348 →
MERGER Recorded Aug 26, 2009
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023146/0415 →
MERGER Recorded Aug 26, 2009
From: ATOM ACQUISITION CORPORATION; APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023146/0456 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →